Insights

Strategic Partnerships Polaris Pharmaceuticals engages in international collaborations and exclusive distribution agreements (LATAM and EMEA) for ADI-PEG20 / PEG-Arginase formats, indicating a readiness to expand through partner channels and regional licenses.

Late-Stage Opportunity The lead program ADI-PEG 20 is in advanced clinical development with Rolling BLA activity for Malignant Pleural Mesothelioma and hepatocellular carcinoma, suggesting strong near-term regulatory and commercial engagement potential.

Market Expansion Recent partnerships and distribution deals with Bioprofarma Bagó (LATAM) and Er-Kim (EMEA) point to a sales strategy that leverages regional partners to access hard-to-treat cancer markets.

Diverse Portfolio In addition to ADI-PEG20, Polaris is pursuing Uricase-PEG 20 for gout and tumor lysis syndrome and a small molecule cancer target program, offering multiple entry points for collaboration and co-development.

Financial & Scale Signals The company operates with a lean team and modest revenue, implying a focus on strategic partnerships, licensing, and contract manufacturing or distribution arrangements to accelerate growth.

Similar companies to Polaris Pharmaceuticals

Polaris Pharmaceuticals Tech Stack

Polaris Pharmaceuticals uses 8 technology products and services including oEmbed, Tencent Exmail, Punycode, and more. Explore Polaris Pharmaceuticals's tech stack below.

oEmbed
Dev Tools
Tencent Exmail
Email
Punycode
Font Scripts
DataTables
Javascript Libraries
Microsoft Windows
Operating Systems
Microsoft Project
Project Management
Minitab
Visualisation Software
Google Search Console
Web Analytics

Media & News

Polaris Pharmaceuticals's Email Address Formats

Polaris Pharmaceuticals uses at least 1 format(s):

Polaris Pharmaceuticals Email Formats	Example	Percentage
FLast@polarispharma.com	JDoe@polarispharma.com	92%
FirstLast@polarispharma.com	JohnDoe@polarispharma.com	5%
FirLast@polarispharma.com	JohDoe@polarispharma.com	2%
First.Last@polarispharma.com	John.Doe@polarispharma.com	1%

Frequently Asked Questions

What is Polaris Pharmaceuticals's phone number?

You can contact Polaris Pharmaceuticals's main corporate office by phone at

+1-858-452-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Polaris Pharmaceuticals's official website and social media links?

Polaris Pharmaceuticals's official website is polarispharma.com and has social profiles on LinkedIn.

What is Polaris Pharmaceuticals's NAICS code?

Polaris Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Polaris Pharmaceuticals have currently?

As of July 2026, Polaris Pharmaceuticals has approximately 26 employees across 2 continents, including North AmericaEurope. Key team members include Associate Manager, Clinical Finance And Contracts: E. V. R.Clinical Trial Specialist Ii: J. B.Regulatory Affairs Consultant: K. L.. Explore Polaris Pharmaceuticals's employee directory with LeadIQ.

What industry does Polaris Pharmaceuticals belong to?

Polaris Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Polaris Pharmaceuticals use?

Polaris Pharmaceuticals's tech stack includes oEmbedTencent ExmailPunycodeDataTablesMicrosoft WindowsMicrosoft ProjectMinitabGoogle Search Console.

What is Polaris Pharmaceuticals's email format?

Polaris Pharmaceuticals's email format typically follows the pattern of FLast@polarispharma.com. Find more Polaris Pharmaceuticals email formats with LeadIQ.

When was Polaris Pharmaceuticals founded?

Polaris Pharmaceuticals was founded in 2006.

Polaris Pharmaceuticals

Q: How many employees does Polaris Pharmaceuticals have currently?

Polaris Pharmaceuticals has approximately 26 employees.

Q: What technology does Polaris Pharmaceuticals use?

Polaris Pharmaceuticals's tech stack includes Astra, JSON-LD, WordPress, Apache HTTP Server, Google Search Console.

Q: What is Polaris Pharmaceuticals's NAICS code?

Polaris Pharmaceuticals's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Polaris Pharmaceuticals is a privately held, multinational biopharmaceutical company focused on the research and development of protein drugs to treat cancer and other human diseases. Based in San Diego, California, the company operates at 6370 Nancy Ridge Drive, Suite 106, San Diego 92121, United States, and employs 11 to 50 people. Its lead program, ADI-PEG 20, is in advanced clinical development for hepatocellular carcinoma and metastatic melanoma. Polaris collaborates with EnzymeRx on the development of Uricase-PEG 20 for gout, tumor lysis syndrome, and other hyperuricemia-related conditions. In addition to biotherapeutics, the company conducts research into other biotherapeutic agents and maintains a small-molecule drug program that uses structure-based design to target cancer-related proteins.